[Asia Economy Reporter Choi Dae-yeol] Chorokbaem Healthcare announced on the 16th that it will acquire approximately 9.84 million shares of Aprogen MED, which conducts biopharmaceutical research and development, for about 18.4 billion KRW. The company decided to exercise the conversion rights of convertible bonds as an investment for profit generation. The shareholding ratio will be 4.8%.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![Clutching a Stolen Dior Bag, Saying "I Hate Being Poor but Real"... The Grotesque Con of a "Human Knockoff" [Slate]](https://cwcontent.asiae.co.kr/asiaresize/183/2026021902243444107_1771435474.jpg)
